By Craig Morgan
Conducting clinical trials is a high stakes game, but disturbingly, the risk of selecting non-performing or underperforming investigative sites is greater than losing at the gambling table. When shooting craps, for example, odds are 17% that the player will role a 7 to start the action, and the odds of actually winning may be even lower. But, the odds of selecting sites that perform well in clinical trials are worse, far worse. More than 80% of clinical trials fail to meet original timelines, with enrollment problems largely to blame, branding the site selection process a perpetual bottleneck.